lorazepam has been researched along with atropine in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 5 (26.32) | 18.7374 |
1990's | 2 (10.53) | 18.2507 |
2000's | 8 (42.11) | 29.6817 |
2010's | 4 (21.05) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrews, PR; Craik, DJ; Martin, JL | 1 |
Duffy, EM; Jorgensen, WL | 1 |
Topliss, JG; Yoshida, F | 1 |
Gao, F; Lombardo, F; Shalaeva, MY; Tupper, KA | 1 |
Gao, F; Lombardo, F; Obach, RS; Shalaeva, MY | 2 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV | 1 |
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM | 1 |
Chang, G; El-Kattan, A; Miller, HR; Obach, RS; Rotter, C; Steyn, SJ; Troutman, MD; Varma, MV | 1 |
García-Mera, X; González-Díaz, H; Prado-Prado, FJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Bellville, JW; Conner, JT; Graham, CW; Katz, RL; Pagano, RR; Schehl, D | 1 |
Edwards, AE; Ferguson, BJ; Gower, DE; Smith, CJ; Williams, CP | 1 |
Auvinen, J; Korttila, K; Levänen, J | 1 |
File, SE; Pearce, JB | 1 |
Lumley, J; Morgan, M; Puchihewa, VG; Whitwam, JG | 1 |
Cole, BJ; Jones, GH | 1 |
Akhileswaran, R; Heng, CP; Hui, D; Tan, A; Yap, R | 1 |
1 review(s) available for lorazepam and atropine
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for lorazepam and atropine
Article | Year |
---|---|
Lorazepam, hyoscine and atropine as i.v. surgical premedicants.
Topics: Adolescent; Adult; Aged; Anti-Anxiety Agents; Anxiety; Atropine; Clinical Trials as Topic; Double-Blind Method; Female; Humans; Infusions, Parenteral; Lorazepam; Male; Mental Recall; Middle Aged; Preanesthetic Medication; Scopolamine | 1978 |
17 other study(ies) available for lorazepam and atropine
Article | Year |
---|---|
Functional group contributions to drug-receptor interactions.
Topics: Animals; Calorimetry; Kinetics; Models, Biological; Protein Binding; Receptors, Cell Surface; Receptors, Drug; Structure-Activity Relationship | 1984 |
Prediction of drug solubility from Monte Carlo simulations.
Topics: Monte Carlo Method; Pharmaceutical Preparations; Solubility | 2000 |
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
ElogD(oct): a tool for lipophilicity determination in drug discovery. 2. Basic and neutral compounds.
Topics: 1-Octanol; Chromatography, High Pressure Liquid; Pharmaceutical Preparations; Solubility; Water | 2001 |
Prediction of volume of distribution values in humans for neutral and basic drugs using physicochemical measurements and plasma protein binding data.
Topics: Blood Proteins; Chemical Phenomena; Chemistry, Physical; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding | 2002 |
Prediction of human volume of distribution values for neutral and basic drugs. 2. Extended data set and leave-class-out statistics.
Topics: Algorithms; Blood Proteins; Half-Life; Humans; Hydrogen-Ion Concentration; Models, Biological; Pharmaceutical Preparations; Pharmacokinetics; Protein Binding; Statistics as Topic; Tissue Distribution | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Physicochemical determinants of human renal clearance.
Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight | 2009 |
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
Topics: | 2008 |
Physicochemical space for optimum oral bioavailability: contribution of human intestinal absorption and first-pass elimination.
Topics: Administration, Oral; Biological Availability; Humans; Intestinal Absorption; Pharmaceutical Preparations | 2010 |
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics | 2010 |
Leucocyte migration: effects of in vitro exposure to anaesthetic agents: possible potentiation of effects by adrenaline.
Topics: Adult; Anesthetics; Atropine; Bupivacaine; Cell Migration Inhibition; Cell Movement; Cell Survival; Drug Synergism; Epinephrine; Humans; Hydrocortisone; Leukocytes; Lidocaine; Lorazepam; Lymphocytes; Middle Aged; Morphine; Norepinephrine; Pancuronium; Succinylcholine; Thiopental | 1992 |
Failure of intramuscularly administered lorazepam and scopolamine-morphine premedication to produce amnesic effects to supplement conduction anaesthesia.
Topics: Adult; Anesthesia, Conduction; Anti-Anxiety Agents; Atropine; Humans; Injections, Intramuscular; Lorazepam; Male; Memory; Meperidine; Morphine; Preanesthetic Medication; Scopolamine | 1980 |
Benzodiazepines reduce gastric ulcers induced in rats by stress.
Topics: Animals; Atropine; Benzodiazepines; Chlordiazepoxide; Cimetidine; Female; Gastric Acid; Gastric Mucosa; Hypnotics and Sedatives; In Vitro Techniques; Lorazepam; Male; Rats; Rats, Inbred Strains; Stomach Ulcer; Stress, Physiological | 1981 |
Respiratory effects of Minaxolone.
Topics: Anesthesia, Intravenous; Anesthetics; Apnea; Atropine; Female; Humans; Lorazepam; Lung Volume Measurements; Papaverine; Preanesthetic Medication; Pregnanes; Pregnanolone; Respiration; Scopolamine | 1980 |
Double dissociation between the effects of muscarinic antagonists and benzodiazepine receptor agonists on the acquisition and retention of passive avoidance.
Topics: Animals; Atropine; Avoidance Learning; Diazepam; GABA-A Receptor Agonists; Lorazepam; Male; Memory; Muscarinic Antagonists; Rats; Rats, Wistar; Scopolamine | 1995 |
Comfort care kit: use of nonoral and nonparenteral rescue medications at home for terminally ill patients with swallowing difficulty.
Topics: Acetaminophen; Adjuvants, Anesthesia; Administration, Rectal; Administration, Sublingual; Adult; Aged; Aged, 80 and over; Analgesics, Non-Narcotic; Analgesics, Opioid; Anti-Anxiety Agents; Antipsychotic Agents; Atropine; Caregivers; Deglutition Disorders; Female; Haloperidol; Home Care Services; Humans; Lorazepam; Male; Middle Aged; Morphine; Palliative Care; Pilot Projects; Singapore; Terminally Ill | 2014 |